Literature DB >> 26195209

Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure.

Sudha Kodali1, Brendan M McGuire2.   

Abstract

Hepatic encephalopathy (HE) is associated with cerebral edema (CE), increased intracranial pressure (ICP), and subsequent neurologic complications; it is the most important cause of morbidity and mortality in fulminant hepatic failure. The goal of therapy should be early diagnosis and treatment of HE with measures to reduce CE. A combination of clinical examination and diagnostic modalities can aid in prompt diagnosis. ICP monitoring and transcranial Doppler help diagnose and monitor response to treatment. Transfer to a transplant center and intensive care unit admission with airway management and reduction of CE with hypertonic saline, mannitol, hypothermia, and sedation are recommended as a bridge to liver transplantation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ammonia; Fulminant hepatic failure; Hepatic encephalopathy; Hyperammonemia

Mesh:

Substances:

Year:  2015        PMID: 26195209     DOI: 10.1016/j.cld.2015.04.006

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  4 in total

1.  Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature.

Authors:  Ruby Upadhyay; Thomas P Bleck; Katharina M Busl
Journal:  Case Rep Med       Date:  2016-09-21

Review 2.  Epigallocatechin-3-Gallate Toxicity in Children: A Potential and Current Toxicological Event in the Differential Diagnosis With Virus-Triggered Fulminant Hepatic Failure.

Authors:  Consolato M Sergi
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

3.  A prognostic score for patients with acute-on-chronic liver failure treated with plasma exchange-centered artificial liver support system.

Authors:  Lingyao Du; Yuanji Ma; Shaoqun Zhou; Fang Chen; Yan Xu; Ming Wang; Xuezhong Lei; Ping Feng; Hong Tang; Lang Bai
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

4.  Mangiferin Attenuates LPS/D-GalN-Induced Acute Liver Injury by Promoting HO-1 in Kupffer Cells.

Authors:  Sen Yang; Ge Kuang; Liangke Zhang; Shengwang Wu; Zizuo Zhao; Bin Wang; Xinru Yin; Xia Gong; Jingyuan Wan
Journal:  Front Immunol       Date:  2020-02-25       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.